Overview
A short-acting version.
Each shot gives you about a 30-minute GH pulse.
Usually paired with Ipamorelin.
What It Does
GHRH analog producing natural pulsatile GH release when injected pre-bed.
Short half-life = clean GH pulse.
Binds GHRH receptors on pituitary somatotrophs.
Reconstitution
| Vial Size | BAC Water / Solvent | Concentration |
|---|---|---|
| 5 mg | + 1 mL | 5 mg/mL |
| 10 mg | + 2 mL | 5 mg/mL |
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Enter a target amount you already have and select the syringe capacity.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Protocol
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Weeks 1–2 | Nightly 5×/week | 200 mcg | 6.0u Start low and assess how your body responds before increasing. |
| Weeks 3–12 | Nightly 5×/week | 300 mcg | 9.0u Standard effective dose for most users. |
| Off | 4 weeks | – | – Off period, let your pituitary and receptors recover before the next cycle. |
8–12 weeks on / 4 weeks off. Max: 12 weeks on / 4–8 weeks off. 5 nights/week (M–F) preferred over daily.
Fasted AM or fasted pre-bed. No food 60–90 min before; no food 60 min after, food-driven insulin blunts the GH pulse. Dose note: GHRH receptors saturate near ~100 mcg; 300 mcg adds little extra GH, mostly cost.
Women make ~3× the GH of men yet have similar IGF-1, they’re less responsive, so often need a higher dose to move IGF-1. Oral estrogen blunts IGF-1 further (read it as running low); a skin patch/gel is more predictable. Men: Men convert GH to IGF-1 more efficiently and more often overshoot the age ceiling (a higher malignancy signal), aim mid-normal for age, don’t chase the Women make ~3× the GH of men yet have similar IGF-1, they’re less responsive, so often need a higher dose to move IGF-1. Oral estrogen blunts IGF-1 further (read it as running low); a skin patch/gel is more predictable. Men: Men convert GH to IGF-1 more efficiently and more often overshoot the age ceiling (a higher malignancy signal), aim mid-normal for age, don’t chase the top.
Handling & Stacking
Safety & Patient Education
- IGF-1 (baseline / mid / end; target ULN for age), Lipid panel (Week 0/12) Fasting glucose and HbA1c at baseline and end of cycle Mammogram and prostate screening per age-appropriate guidelines before starting Out of range?
- IGF-1 above your age range = too much growth signal (feeds hidden cancer, enlarges organs) → drop the dose; rising glucose/HbA1c = sugar creeping up.
